5.ALPHA.-ANDROST-16-ENE-6.BETA.,17-DIOL-DI-TRIMETHYLSILYL ETHER
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | 9UWdOQzzwwF |
|---|---|
| InChI | InChI=1S/C25H46O2Si2/c1-24-15-10-9-11-21(24)22(26-28(3,4)5)17-18-19-12-13-23(27-29(6,7)8)25(19,2)16-14-20(18)24/h13,18-22H,9-12,14-17H2,1-8H3/t18-,19-,20-,21+,22+,24+,25-/m0/s1 |
| InChIKey | CZEFEHMHJGIIEY-YKEKKNTNSA-N |
| Mol Weight | 434.8 g/mol |
| Molecular Formula | C25H46O2Si2 |
| Exact Mass | 434.303634 g/mol |
| Enantiomer InChIKey | CZEFEHMHJGIIEY-DNGWBSEMSA-N |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Dr. Makin, London Hospital Medical College, UK |
- ((5S,6R,8R,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthrene-6,17-diyl)bis(oxy)bis(trimethylsilane)
- 6,17-BIS[(TRIMETHYLSILYL)OXY]ANDROST-16-ENE
3alpha,17-bis-trimethylsilyloxy-6alpha-methyl-5beta-androstan-16-ene
Androsterone 16-enol , O,O'-bis-TBS
3,17-bis-trimethylsilyloxy-6alpha-Methyl-5beta-androstane-3,16-diene
[(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-3-[tris(trideuteriomethyl)silyloxy]-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]oxy-tris(trideuteriomethyl)silane
3.BETA.,6.ALPHA.-DI-[(TRIMETHYLSILYL)OXY]-5.ALPHA.-ANDROSTANE-17-ONE-17-(O-METHYLOXIME)
5.BETA.-ANDROSTANE-3.ALPHA.,6.ALPHA.-DIOL-17-ONE(17-O-METHYLOXIME-3.ALPHA.,6.ALPHA.-DI-TRIMETHYLSILYL ETHER)
Silane, [[(3.beta.,5.alpha.,6.beta.)-cholestane-3,6-diyl]bis(oxy)]bis[ethenyl dimethyl-
Silane, [[(3.beta.,5.alpha.,6.alpha.)-cholestane-3,6-diyl]bis(oxy)]bis[etheny ldimethyl-
This compound is available in the following databases:
Mass Spectra of Physiologically Active Substances - including drugs, steroid hormones,and endocrine disruptors 2011
Author: Parr, Maria Kristina; Opfermann, Georg; Schänzer, Wilhelm; Makin, Hugh L. J.
Fast and reliable identification of trace steroids requires an up-to-date library covering most known and newly emerging steroids. It is updated annually. Learn more.